1. EachPod

End of Day Report – Thursday 4 September: Bounce back day | US holds, gold eases, bonds relax

Author
Marcus Today
Published
Thu 04 Sep 2025
Episode Link
None

The ASX 200 has bounced back 88 points or 1% to 8827. Still down 72 points since the close on Tuesday. Financials stayed on top. ‘Big Three’ plus MQG all up 2%. ANZ up 1.3%. ZIP up 3.6%. Gold the only sector in the red despite bullion maintaining its record high. Discretionary stocks no. 2. Most of the gain driven by WES up 2.5%. Has already recovered all its ex-dividend drop. DMP lost most of its morning gains. Tech no. 3. Not the huge bounce we were expecting following the Nasdaq’s rise. XRO went from worst in the Top 50 to best. Up 4.8%. Good to see it, WES, CBA, MQG, NAB, WBC and PME along with HUB in the top gainers table. WTC lifeless and NXT finally gave it to a bout of profit taking.

Defence stocks mixed as traders digest China’s military show. EOS and ASB jumped while DRO and CDA only recorded small wins. Resources ended flat. Solid day from iron ore (back up to $105 in Singapore) and copper offset by gold. BHP only fell 31c vs its ~92c dividend. Lithium mixed. LTR, MIN and PLS all up over 1% while PMT and WC8 dropped. Excellent day for uranium. DYL up 6%, BOE up 5%, NXG up 4% and PDN up 2%. LOT closed at 18c (-20%) vs the 19c placement. Telecoms flat too. Health Care strong thanks to CSL and PME up 2.1% and 1.9%. 4DX the major mover. Up 13.4%. Backing up its huge 50% rise yesterday on US reimbursement certainty.

Asian markets more converse since midday. Japan up 1%. China down 1.2%. No lead from US futures. Broadcom results early tomorrow morning.

Want to invest with Marcus Today? The Managed Strategy Portfolio is designed for investors seeking exposure to our strategy while we do the hard work for you.

If you’re looking for personal financial advice, our friends at
Clime Investment Management can help. Their team of licensed advisers operates across most states, offering tailored financial planning services.
 
 Why not
sign up for a free trial? Gain access to expert insights, research, and analysis to become a better investor.

Share to: